Advertisement

Topics

Chad Therapeutics Company Profile

11:29 EDT 19th September 2017 | BioPortfolio

We are the innovators and manufacturers of cost efficient, user friendly stationary and ambulatory oxygen systems designed for use by patients diagnosed with COPD and other respiratory disorders. As the leader in oxygen conservation, we take pride in providing some of the lightest weight, longest lasting portable oxygen systems available today. It is the innovative technology of our extensive line of electronic and pneumatic oxygen conservers, as well as our revolutionary in-home filling system that have set the pace for a new dimension in the home oxygen market.



Provided through an extensive network of homecare providers and global distributors, our state-of-the-art line of oxygen systems allows the homecare provider to reduce operating costs, thereby increasing profits. And, patient base and revenues can be expanded with the same resources as a result of less frequent servicing requirements and inventory maintenance. In fact, substantial reductions in operating costs can be realized by using our oxygen systems when compared to liquid oxygen and other traditional oxygen delivery systems.



Our line of quality products enables home oxygen patients to maintain an active lifestyle and reclaim the mobility and freedom they deserve. At CHAD Therapeutics, we enjoy making a difference in people's lives!

Location

21622 Plummer Street
Chatsworth
CA
91311
United States of America

Contact

Phone: 1-800-423-8870
Fax: 818-882-1809
Email: bmuskin@chadtherapeutics.com .


News Articles [1544 Associated News Articles listed on BioPortfolio]

Chad Carr's tumor offers genetic clues for DIPG research

(Michigan Medicine - University of Michigan) A year and half after losing his battle against brain cancer, Chad Carr's legacy lives through research that will help other children facing the same cruel...

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.

Aflac Was #ThereWhen

SOURCE: Aflac DESCRIPTION:Aflac was #ThereWhen Aflac employee and policyholder Chad Melvin’s son was diagnosed with a very rare blood disorder called LCH. What started as a day at the pool became ...

ProQR spins out Amylon Therapeutics for CNS therapeutics

ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of inst...

Summit Therapeutics PLC (SMMT) and Orexigen Therapeutics (OREX) Head to Head Review

Summit Therapeutics PLC and Orexigen Therapeutics are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, in...

How Hospitalists Can Reach the C-Suite

Chad Whelan, MD, who was recently named president of Loyola University Medical Center, shares his best career tips. Medscape Internal Medicine

RaNA Therapeutics Relaunches as Translate Bio to Advance RNA Therapeutics

Tuesday, June 27th 2017 at 11:00am UTC — Company Expands Executive Leadership Team with Key Appointments in Early 2017 — CAMBRIDGE, Mass.–(BUSINESS WIRE)– RaNA Therapeutics tod...

CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration

CAMBRIDGE, Mass. and BASEL, Switzerland, July 10, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines...

PubMed Articles [565 Associated PubMed Articles listed on BioPortfolio]

Proteins with CHAD Domains (Conserved Histidine α-Helical Domain) Are Attached to Polyphosphate (polyP) Granules in vivo and Constitute a Novel Family of PolyP-Associated Proteins (Phosins).

Based on bioinformatic evidence, we suspected that proteins with a CYTH domain (CyaB thiamine tri-phosphatase) and/or a CHAD motif (conserved-histidine-α-helical-domain) could represent polyP granule...

The omitted epidemic-hepatitis E in the Lake Chad region.

Adding tsetse control to medical activities contributes to decreasing transmission of sleeping sickness in the Mandoul focus (Chad).

Gambian sleeping sickness or HAT (human African trypanosomiasis) is a neglected tropical disease caused by Trypanosoma brucei gambiense transmitted by riverine species of tsetse. A global programme ai...

Recurrence of Guinea Worm Disease in Chad after a 10-Year Absence: Risk Factors for Human Cases Identified in 2010-2011.

A decade after reporting its last case of Guinea worm disease (GWD), a waterborne parasitic disease targeted for eradication, Chad reported 20 confirmed human cases from 17 villages-10 cases in 2010 a...

Robert Burton Nussenblatt, MD, MPH (1948-2016), Physician-Scientist, Leading Ophthalmologist and Exemplary Teacher.

Clinical Trials [119 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Prevalence Survey of Plasmodium Falciparum Antimalarial Drug Resistance Markers

This study is to measure prevalence of established and candidate molecular markers of drug resistant malaria at Komé, Doba, Republic of Chad.

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1146 Associated Companies listed on BioPortfolio]

Chad Therapeutics

We are the innovators and manufacturers of cost efficient, user friendly stationary and ambulatory oxygen systems designed for use by patients diagnosed with COPD and other respiratory disorders. As ...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

Click Therapeutics, Inc.

Click Therapeutics, Inc. engineers, validates, and commercializes Digital Therapeutics™ solutions to benefit people with unmet medical needs through cognitive and neurobehavi...

More Information about "Chad Therapeutics" on BioPortfolio

We have published hundreds of Chad Therapeutics news stories on BioPortfolio along with dozens of Chad Therapeutics Clinical Trials and PubMed Articles about Chad Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chad Therapeutics Companies in our database. You can also find out about relevant Chad Therapeutics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...


Corporate Database Quicklinks



Searches Linking to this Company Record